Hsinchu, Taiwan

Yow-Lone Chang


Average Co-Inventor Count = 4.4

ph-index = 1


Company Filing History:


Years Active: 2011-2013

where 'Filed Patents' based on already Granted Patents

2 patents (USPTO):

Title: Yow-Lone Chang: Innovator in Azaazulene Compounds and GABA Analogs

Introduction

Yow-Lone Chang is a notable inventor based in Hsinchu, Taiwan. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds that have potential applications in cancer treatment. With a total of 2 patents, his work reflects a commitment to advancing medical science.

Latest Patents

Chang's latest patents include innovative compounds that are designed to address critical health issues. One of his patents focuses on azaazulene compounds, which are characterized by a specific formula. These compounds can be utilized in treating cancer, and the invention also outlines a method for administering these compounds effectively to patients in need. Another patent involves GABA analogs, which includes pharmaceutical compositions and methods for their synthesis. These advancements highlight Chang's dedication to improving therapeutic options for patients.

Career Highlights

Throughout his career, Yow-Lone Chang has worked with esteemed organizations such as the Industrial Technology Research Institute and Anchen Laboratories, Inc. His experience in these institutions has allowed him to collaborate with other professionals and contribute to groundbreaking research in his field.

Collaborations

Chang has collaborated with notable colleagues, including On Lee and Chih-Hung Chen. These partnerships have played a crucial role in the development of his innovative patents and have fostered a collaborative environment for research and development.

Conclusion

Yow-Lone Chang's contributions to the field of pharmaceuticals, particularly through his patents on azaazulene compounds and GABA analogs, demonstrate his innovative spirit and commitment to advancing medical science. His work continues to inspire future research and development in cancer treatment.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…